SAN DIEGO - A California federal judge on Nov. 19 denied final approval of a $25.3 million Hydroxycut weight loss supplement settlement, saying the proposed cy pres distribution did not meet the standards of the Ninth Circuit U.S. Court of Appeals (In Re: Hydroxycut Marketing and Sales Practices Litigation, No. 3:09-md-2087, Andrew Dremak, et al. v. Iovate Health Sciences Group, Inc., et al., No. 3:09-1088, S.D. Calif.).